Breast cancer, affecting primarily women, is one of the most common cancers with increasing survival rates, yet treatment remains an area for improvement.1 As of 2019, female breast cancer has the highest rates of new diagnoses and is the second highest in number of cancer-related deaths in ...
Melatonin in high doses (at least 20 mg) supports apoptosis of cancer cells, reduces the signals for tumor growth, and improves quality of life during active conventional treatment. NEW CANCER TREATMENTS AND BREAKTHROUGHS... Potential Cure Discovered?
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer Although early breast cancer (BC) is highly curable, advanced or metastatic disease poses numerous challenges in terms of medical management and treatment ... CS Paola,G Daniele - 《Drug Design Development &...
Trastuzumab Deruxtecan Meets Primary End Point in the DEBBRAH Trial for Patients with HER2+ Advanced Breast Cancer Alexandra Gerlach, Associate Editor February 12th 2025 FDA Grants Rezpegaldesleukin Fast Track Designation for Treatment of Children, Adults With Atopic Dermatitis Alexandra Gerlach, Associ...
Cone launched its Breast Cancer Awareness Collection with a nod to pink, partnering with the Alight Program, which provides financial, educational, and emotional support to women and families navigating diagnosis and treatment. Secondly, Cone released its Pride Selvage Community...
Improving Endocrine Therapy for Breast Cancer: It's Not That Simple Endocrine therapy is the mainstay of treatment for estrogen receptor (ER)-positive breast cancer and often represents the first several lines of treatment ... EC Dees,LA Carey - 《Journal of Clinical Oncology Official Journal of...
Last yearanother study led by Janelsins—one of the largest to date for this problem—showed that women with breast cancer continued to report cognitive deficits for as long as six months after finishing treatment. That study not only validated that chemo-brain was pervasive, but Janelsins and...
Breast Cancer Research and Treatment 2012;133:237-46.Kuter I, Gee JM, Hegg R, et al. Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II study. Breast Cancer Res Treat 2012; 133:237-46....
The article presents information on how to reduce risk for certain type of diseases and disorder. It states that more than 2,000 Chinese women who consumed green tea and mushrooms everyday were found to have a lower risk of developing breast cancer. It cites that men over the age of 60 ...